These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 4621798)

  • 21. Stability of the rabbit immunogenic marker of RA 27-3 rubella vaccine virus after human passage.
    Linnemann CC; Hutchinson L; Rotte TC; Hegg ME; Schiff GM
    Infect Immun; 1974 Mar; 9(3):547-9. PubMed ID: 4206028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies on rubella virus. II. Hemagglutination and hemagglutination-inhibition test.
    Yamane Y; Nagashima T; Takada M; Ikumi H; Owada Y
    Kitasato Arch Exp Med; 1970 Jun; 43(1):11-21. PubMed ID: 5535193
    [No Abstract]   [Full Text] [Related]  

  • 23. Attenuated rubella viruses. Laboratory and clinical characteristics.
    Meyer HM; Parkman PD; Hobbins TE; Larson HE; Davis WJ; Simsarian JP; Hopps HE
    Am J Dis Child; 1969 Aug; 118(2):155-65. PubMed ID: 4978508
    [No Abstract]   [Full Text] [Related]  

  • 24. In vivo properties of attenuated rubella virus, "Cendehill" strain.
    Zygraich N; Peetermans J; Huygelen C
    Arch Gesamte Virusforsch; 1971; 33(3):225-33. PubMed ID: 5000190
    [No Abstract]   [Full Text] [Related]  

  • 25. Immunity to intranasal challenge with Rubella virus two years after vaccination: comparison of three vaccines.
    Grillner L
    J Infect Dis; 1976 Jun; 133(6):637-41. PubMed ID: 932491
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Persistence of vaccine-induced immune responses to rubella: comparison with natural infection.
    Horstmann DM; Schluederberg A; Emmons JE; Evans BK; Randolph MF; Andiman WA
    Rev Infect Dis; 1985; 7 Suppl 1():S80-5. PubMed ID: 4001740
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Live attenuated rubella virus vaccines prepared in duck embryo cell culture. I. Development and clinical testing.
    Buynak EB; Hilleman MR; Weibel RE; Stokes J
    JAMA; 1968 Apr; 204(3):195-200. PubMed ID: 4172467
    [No Abstract]   [Full Text] [Related]  

  • 28. Exposure of susceptible pregnant women to rubella vaccinees. Serologic findings during the Rhode Island immunization campaign.
    Scott HD; Byrne EB
    JAMA; 1971 Jan; 215(4):609-12. PubMed ID: 5107437
    [No Abstract]   [Full Text] [Related]  

  • 29. A comparative field evaluation of three live, attenuated rubella virus vaccines.
    Kehrer AF; Isacson P
    Am J Public Health; 1971 Jan; 61(1):152-6. PubMed ID: 5539842
    [No Abstract]   [Full Text] [Related]  

  • 30. Production of rubella antiserum in hamsters.
    Haire M
    J Med Microbiol; 1969 Aug; 2(3):376-9. PubMed ID: 4932021
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical trial of live attenuated rubella virus vaccine, HPV-77 strain.
    Cooper LZ; Giles JP; Krugman S
    Am J Dis Child; 1968 Jun; 115(6):655-7. PubMed ID: 4968322
    [No Abstract]   [Full Text] [Related]  

  • 32. An immunologic marker technique for the Cendehill vaccine strain of rubella virus.
    Oxford JS; Potter CW
    J Immunol; 1970 Oct; 105(4):818-23. PubMed ID: 5470523
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical studies with experimental live rubella virus vaccine (strain HPV-77). Evaluation of vaccine-induced immunity.
    Meyer HM; Parkman PD; Hobbins TE; Ennis FA
    Am J Dis Child; 1968 Jun; 115(6):648-54. PubMed ID: 4968321
    [No Abstract]   [Full Text] [Related]  

  • 34. Genetic stability in humans of the rabbit immunogenic marker of Cendehill rubella vaccine virus.
    Gill SD; Furesz J
    Arch Gesamte Virusforsch; 1973; 43(1):135-43. PubMed ID: 4793528
    [No Abstract]   [Full Text] [Related]  

  • 35. Further studies of an attenuated rubella strain grown in WI-38 cells.
    Plotkin SA; Farquhar JD; Katz M; Hertz C
    Am J Epidemiol; 1969 Feb; 89(2):232-8. PubMed ID: 5765961
    [No Abstract]   [Full Text] [Related]  

  • 36. Production and testing of rubella virus vaccine. Prepared on WI-38 cell cultures.
    Tint H; Rosanoff EI
    Am J Dis Child; 1969 Aug; 118(2):367-71. PubMed ID: 4978515
    [No Abstract]   [Full Text] [Related]  

  • 37. Attenuated rubella vaccine (HPV-77): evaluation in a large controlled trial.
    Lipman RP; Bethel MB; Wooten JH; Levine RH; Pagano JS
    Am J Public Health; 1971 Jul; 61(7):1392-402. PubMed ID: 4935166
    [No Abstract]   [Full Text] [Related]  

  • 38. Rubella immunization with HPV-77 DE5 vaccine during infancy.
    Herrmann KL; Wende RD; Witte JJ
    Am J Dis Child; 1971 Jun; 121(6):474-6. PubMed ID: 5581013
    [No Abstract]   [Full Text] [Related]  

  • 39. Antibody response in serum and nasopharynx after naturally acquired and vaccine-induced infection with rubella virus.
    Ogra PL; Kerr-Grant D; Umana G; Dzierba J; Weintraub D
    N Engl J Med; 1971 Dec; 285(24):1333-9. PubMed ID: 4107718
    [No Abstract]   [Full Text] [Related]  

  • 40. Reinfection with rubella virus despite live vaccine induced immunity. Trials of HPV-77 and HPV-80 live rubella virus vaccines and subsequent artificial and natural challenge studies.
    Wilkins J; Leedom JM; Portnoy B; Salvatore MA
    Am J Dis Child; 1969 Aug; 118(2):275-94. PubMed ID: 5794818
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.